Shield Therapeutics plc
SHIEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $31 | $47 | $16 | $87 |
| - Cash | $7 | $14 | $3 | $12 |
| + Debt | $26 | $20 | $6 | $0 |
| Enterprise Value | $51 | $54 | $19 | $75 |
| Revenue | $32 | $13 | $5 | $2 |
| % Growth | 145.9% | 187.7% | 199.5% | – |
| Gross Profit | $15 | $4 | $2 | $1 |
| % Margin | 46.4% | 30.8% | 44.7% | 35.5% |
| EBITDA | -$21 | -$30 | -$25 | -$19 |
| % Margin | -66.1% | -231.5% | -539.6% | -1,234.6% |
| Net Income | -$27 | -$33 | -$50 | -$20 |
| % Margin | -84.5% | -254.4% | -1,094.5% | -1,295.5% |
| EPS Diluted | -0.03 | -0.046 | -0.21 | -0.092 |
| % Growth | 34.9% | 78% | -128.5% | – |
| Operating Cash Flow | -$7 | -$29 | -$18 | -$17 |
| Capital Expenditures | -$2 | -$3 | -$2 | -$2 |
| Free Cash Flow | -$9 | -$40 | -$20 | -$19 |